Tirzepatide, this novel medication, is generating considerable interest within the healthcare community. It works differently from common diabetes medications, targeting two receptors involved in blood regulation and appetite . Initial trials have demonstrated remarkable efficacy in controlling blood glucose in individuals with type 2 diabetes and,